Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
new york blog main
16
×
venture capital
16
×
boston blog main
life sciences
national top stories
san diego blog main
san francisco blog main
biotech
boston top stories
raleigh-durham blog main
seattle blog main
detroit blog main
indiana blog main
national
san diego top stories
texas blog main
wisconsin blog main
boulder/denver blog main
new york top stories
startups
texas top stories
vc
detroit top stories
raleigh-durham top stories
san francisco top stories
seattle top stories
wisconsin top stories
boulder/denver top stories
indiana top stories
cancer
fda
ipo
biogen
clinical trials
deals
medical devices
novartis
boston
celgene
What
bio
roundup
ipo
medicines
new
company
developing
drugs
investors
million
patients
science
car
ceo
covid
fda
gene
help
hot
life
market
payers
plans
real
talk
therapy
years
abbvie’s
acquisitions
activity
acutus
adds
advance
advantages
ahead
aims
allogene
announced
approvals
aren’t
Language
unset
Current search:
" venture capital "
×
" new york blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”